ALB and esophageal squamous cell carcinoma: Clinical data from 166 patients with ESCC who received two courses of chemotherapy with 5-fluorouracil plus cisplatin (109 in the CRT group and 57 patients in the NAC group) were examined, along with 166 matched healthy controls.<h4>Results</h4>Compared with healthy controls, patients with ESCC had poorer nutritional status as assessed using serum albumin levels, body mass index (BMI), and psoas muscle mass index (PMI), which declined further during treatment.